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Abstract 
Objectives​: To evaluate the performance of an Artificial Intelligence (AI) system (Pegasus,            
Visulytix Ltd., UK), at the detection of Diabetic Retinopathy (DR) from images captured by a               
handheld ​ portable fundus camera. 
 
Methods​: A cohort of 6,404 patients (~80% with diabetes mellitus) was screened for retinal              
diseases using a handheld portable fundus camera (Pictor Plus, Volk Optical Inc., USA) at              
the Mexican Advanced Imaging Laboratory for Ocular Research. The images were graded for             
DR by specialists according to the Scottish DR grading scheme. The performance of the AI               
system was evaluated, retrospectively, in assessing Referable DR (RDR) and Proliferative           
DR (PDR) and compared to the performance on a publicly available desktop camera             
benchmark dataset. 
 
Results​: For RDR detection, Pegasus performed with an 89.4% (95% CI: 88.0-90.7) Area             
Under the Receiver Operating Characteristic (AUROC) curve for the MAILOR cohort,           
compared to an AUROC of 98.5% (95% CI: 97.8-99.2) on the benchmark dataset. This              
difference was statistically significant. Moreover, no statistically significant difference was          
found in performance for PDR detection with Pegasus achieving an AUROC of 94.3% (95%              
CI: 91.0-96.9) on the MAILOR cohort and 92.2% (95% CI: 89.4-94.8) on the benchmark              
dataset. 
 
Conclusions​: Pegasus showed good transferability for the detection of PDR from a curated             
desktop fundus camera dataset to real-world clinical practice with a handheld portable fundus             
 
camera. However, there was a substantial, and statistically significant, decrease in the            
diagnostic performance for RDR when using the handheld device. 
Introduction 
Diabetic Retinopathy (DR) imparts a significant burden on healthcare services worldwide. It            
is estimated that one third of the 285 million people with diabetes worldwide will have some                
degree of DR and 50% of patients with proliferative diabetic retinopathy will lose vision              
within 5 years. ​1 By 2030, the number of people with diabetes is likely to reach 552 million.​1                 
In contrast, the growth in the number of ophthalmologists is unlikely to match the increasing               
demand.​2,3 
 
Deep learning-based Artificial Intelligence (AI) systems have shown promise across a           
number of healthcare imaging domains. For example, Esteva et al. describe a study whereby              
a group at Stanford University trained a system to classify skin lesions from photographs.​4              
The performance of detecting malignant melanomas and carcinomas was found to match that             
of 21 board-certified dermatologists. Similar networks have been developed to detect breast            
cancer with equivalent accuracy to experts.​5  
 
Within the field of ophthalmology, algorithms to detect and classify DR have been developed              
since at least 2010.​6 However, to our knowledge, no research is available on the performance               
of such deep learning-based systems with portable ​handheld cameras, which are often used in              
real-world clinical screening programs. There is little evidence that the performance of deep             
learning systems, trained and tested on conventional desktop cameras, is transferable to            
images from handheld devices. 
 
 In this study, we evaluate the performance of a deep learning system (Pegasus, Visulytix Ltd.,               
UK) at detecting Referable DR (RDR) and Proliferative DR (PDR), retrospectively, on a             
cohort of patients screened at the Mexican Advanced Imaging Laboratory for Ocular            
Research (MAILOR). These results are compared to a “benchmark” performance of the            
software as determined on a publicly available dataset of curated fundus images from a              
conventional desktop device.​7 
Materials and Methods 
Data Collection 
The data was collected at the Mexican Advanced Imaging Laboratory for Ocular Research             
(MAILOR). This study adhered to the tenets of the Declaration of Helsinki. A cohort of               
participants was randomly selected from patients who attended the clinic between October            
2016 and March 2017. Patients were screened for retinal diseases using a 40-degree             
Field-of-View (FoV) non-mydriatic handheld fundus camera (Pictor Plus, Volk Optical Inc.,           
USA). Images were analysed and graded by a board of experts. Each grader was certified               
from both the Singapore Eye Research Institute and Melbourne University for fundus image             
reading. 
 
The Indian Diabetic Retinopathy image Dataset (IDRiD),​7 an independent and publicly           
available dataset, was employed as a “benchmark” dataset. This dataset is highly curated and              
contains good quality images captured from a conventional mydriatic 50-degree FoV desktop            
camera (VX-10 alpha, Kowa American Corp., USA). The images have a resolution of             
 
4288-by-2848 pixels and were captured by a retinal specialist at an eye clinic located in               
Nanded, Maharashtra, India. The dataset is representative of the Indian population and there             
was no overlap between patients enrolled in the MAILOR study, and patients screened in the               
benchmark dataset. The dataset is not necessarily representative of clinical practice, but we             
believe that it provides a good benchmark for the upper bound on the range of diagnostic                
performance of the software. 
 
Handheld cameras offer some benefits compared to desktop ones when used in screening             
programs. In particular, they offer mobility and flexibility, making it easier to screen patients              
in remote locations. However, the quality of the resultant images is usually lower than              
conventional desktop cameras.​8 Figure 1 shows examples from the MAILOR study and the             
benchmark dataset, and highlights the difference in image quality. 
 
Screening Protocol 
In the MAILOR study, four fundus images were captured per patient; one disc-centred and              
one macula-centred per eye. The quality of each image was assessed to determine whether it               
was adequate for the purposes of grading. This includes the following rules: (i) an image with                
visible referable retinopathy or maculopathy is always adequate for grading; and (ii) an image              
with adequate field definition (entire optic disc imaged and a fovea at least two disc               
diameters from the image edge) and clarity (third-generation vessels radiating around the            
fovea must be visible) is adequate for grading.​9 
 
 
Images identified as ungradable by the graders were not assessed for retinal disease. Each eye               
with at least one gradable image was assessed for DR and graded by at least one grader,                 
providing DR and Diabetic Maculopathy (DM) grades according to the Scottish grading            
system.​9 Second readings were performed in approximately 10% of examinations for quality            
assurance. In these cases, if a discrepancy with the first reader was identified, the image was                
graded again by a third expert who took into account both the image and the grades of the                  
initial graders. This was taken as the final grade. 
 
In total, 25,616 fundus images were captured from the initial MAILOR cohort of 6,404              
patients. Images from 5,752 patients were subsequently analysed, after excluding unlabelled           
and ungradable images (Figure 2). Patient and image characteristics are shown in Table 1. It               
was found that the prevalence of diabetes mellitus in the MAILOR cohort (~80%) was higher               
than the expected population prevalence. This could be attributed to the fact that the              
participants are in most cases newly diagnosed diabetic patients. A lower than expected DR              
prevalence was found in the cohort, given the number of diabetic patients. This could be               
explained by the fact that patients already diagnosed with diabetic retinopathy might not             
consider it necessary to enter the study. 
 
The benchmark dataset (IDRiD) consists of 516 fundus photographs graded by experts for             
diabetic retinopathy according to the International Clinical Diabetic Retinopathy (ICDR)          
disease severity scale.​10 All benchmark images are macula-centred, with a clear view of the              
optic disc. Experts also verified that all images were of adequate quality, clinically relevant,              
that no image was duplicated, and representative of all DR grades.​7 
 
Data Processing 
In this study, the images were uploaded to the deep learning system, Pegasus (Visulytix Ltd.,               
UK), and the performance of its DR detection feature was assessed. Pegasus is a decision               
support tool for screening for a number of major eye diseases. For DR screening, Pegasus               
provides a DR grade per image, as well as visual representations of detected microaneurysms,              
exudates and haemorrhages overlaid on the original image. The system also provides a             
quality control feature to confirm, for each image, that the correct type of image was               
uploaded, and that it is of sufficient quality to be graded. The DR output from Pegasus was                 
used to generate the prediction for the presence of RDR and/or PDR for each patient.  
 
Pegasus assesses images for diabetic retinopathy according to the ICDR scale​10 ​in order to              
integrate with the majority of clinical workflows used around the world. However, MAILOR             
employs the Scottish grading scheme.​9 RDR corresponds to a DR of grade 2 or above in the                 
ICDR scale, and in the Scottish scheme, RDR is defined as R2 or above, or DM 1. In both                   
systems, PDR is defined by the same characteristics.  
 
The use of two different grading schemes can lead to disagreements when grading an image               
for RDR. This occurs when haemorrhages are present in the retina, but none of the hemifields                
contains four or more of them, or when there are exudates present in the image farther than                 
one disc diameter from the fovea. In these cases, the image would be considered as referable                
under the ICDR scale, but not by the Scottish scheme. 
 
 
All images were uploaded to a locally hosted version of the Pegasus platform using a               
Python-based Application Programming Interface (API) in a continuous fashion with 8 image            
processing requests made in parallel from the client computer. No image pre-processing was             
applied prior to upload; the raw images were uploaded directly to Pegasus. 
 
For the MAILOR study, diagnostic performance was assessed in three ways: (i) on a              
patient-by-patient basis where the diagnosis for the patients was taken as the worst outcome              
from Pegasus across the four images acquired; (ii) on an image-by-image basis considering             
disc-centered fields only; (iii) on an image-by-image basis considering macula-centered fields           
only. 
Statistical Analysis 
The performance of the AI system was measured for RDR and PDR. The prediction for the                
presence of RDR and/or PDR for each patient was compared to the reference standard. The               
performance was assessed using Receiver Operating Characteristic (ROC) analysis to          
determine the sensitivity, specificity and Area Under the ROC curve (AUROC). Confidence            
Intervals (CI) at the 95% significance level were determined using bootstrap sampling with             
1,000 replications for all metrics reported. Randomised permutation testing with 1,000           
samples was used for testing whether differences in performance were statistically           
significant. Statistical significance was defined at p<0.05. 
Results 
There were no processing errors for any of the images. For MAILOR, processing was              
performed at an average speed of 2.16 seconds/image for the 22,180 images. The IDRiD              
 
dataset was processed in a similar way but with an average speed of 1.07 seconds/image for                
516 images. Pegasus gave average gradability scores of 84.8% (standard deviation: 19.6%)            
and 44.6% (standard deviation: 35.1%) for IDRiD and MAILOR images, respectively. 
 
Results for Pegasus for both the MAILOR study and the benchmark dataset are shown in               
Table 2. On images from the handheld camera, Pegasus achieved an AUROC of 89.4% (95%               
CI: 88.0-90.7) when detecting RDR, corresponding to a sensitivity of 81.6% (95% CI:             
79.0-84.2) and at a specificity of 81.7% (95% CI: 80.9-82.6), at an operating point chosen               
such that the sensitivity and specificity were approximately equal. When detecting PDR,            
Pegasus obtained an AUROC of 94.3% (95% CI: 91.0-96.9), corresponding to a sensitivity of              
86.6% (95% CI: 78.9-93.5) and specificity of 87.7% (95% CI: 87.0-88.4). The corresponding             
ROC curves are shown in Figure 3. Selected examples of false positives are given in Figure                
5. 
 
When assessed on the desktop camera benchmark dataset, Pegasus obtained an AUROC of             
98.5% (95% CI: 97.8-99.2) for RDR, with corresponding sensitivity and specificity of 93.4%             
(95% CI: 90.8-95.8) and 94.2% (95% CI: 91.0-97.2), respectively. For PDR, the AI system              
achieved an AUROC of 92.2% (95% CI: 89.4-94.8), with a sensitivity of 83.7% (95% CI:               
74.5-91.8) and specificity of 84.6% (95% CI: 81.5-87.7). The corresponding ROC curves are             
shown in Figure 6.  
 
The AUROC difference for RDR detection was substantially lower for patients from the             
MAILOR study than the IDRiD benchmark dataset. This difference was statistically           
significant (p<0.001). There was approximately a 12-13% disparity in the RDR           
 
sensitivity/specificity performances between the handheld and benchmark desktop devices.         
For PDR, Pegasus performed slightly better on the MAILOR cohort than the benchmark             
dataset in terms of AUROC, however this difference was not statistically significant            
(p=0.172). 
 
Additionally, the RDR performance of Pegasus was compared when using only           
macula-centred images for a patient against disc-centred images. It was determined that there             
was a statistically significant difference in AUROCs (p=0.003). The RDR AUROC           
performance improved by 2.3% when using a macula-centred field over a disc-centred field.  
Discussion 
The performance of Pegasus for RDR was statistically significantly, and substantially, lower            
on the MAILOR cohort using the handheld portable camera than on the benchmark dataset              
using the conventional desktop camera. There are a number of possible factors that could              
explain this: 
1. The Pegasus software performance for RDR does not generalise well from a curated             
conventional desktop dataset to a real-world patient cohort imaged using a handheld            
portable fundus camera due to poor image quality and other factors; 
2. The mismatch in the grading system expected by the software and the grading system              
used in the Clinical Reference Standard (CRS), led to an increase in “false positives”; 
3. The CRS was substantially worse in the MAILOR study than in the curated             
benchmark dataset, due to the difficulty in assessing subtle DR features such as dot              
haemorrhages in the poorer quality images from the handheld device; 
 
4. Inclusion of disc-centred images leads to substantially worse diagnoses for a patient            
over just scanning their macula. 
 
The answer is likely a combination of the above factors, however, it appears that the biggest                
contributing factor is the mismatch in grading systems. This is because there is evidence that               
the software algorithm does generalise in the case of PDR where the grading systems              
perfectly coincide, and it was observed that there were a number of RDR false positives (see                
Figure 4) which were due to grading system mismatches. In addition, the performance on the               
disc-centred field is statistically significantly worse than on macula-centred fields, although           
not substantially so. This implies the effect of disc-centred images on overall patient             
diagnosis is small. Image quality may play a role since the Pegasus quality control feature               
detected that the quality of the images from the handheld camera is substantially lower than               
for the desktop camera, which can have an effect on the detection of DR. 
 
Overall Pegasus performed well for PDR detection on both the handheld portable camera             
(MAILOR cohort) and the curated benchmark dataset (IDRiD), with no statistically           
significant difference between the two image types. This implies that the software algorithm             
can generalise to other image types, at least in the case of PDR. 
 
The main limitations of this study include: (i) the CRS was determined by manual grading of                
images and not the final clinical diagnosis, and (ii) the mismatch between the CRS grading               
system and the software grading system. While these limitations complicate the interpretation            
of the results for RDR, in particular, they raise some important points about the use of deep                 
 
learning software in clinical practice. First, organisations should ensure that the deep learning             
system uses the same grading system as the rest of the screening program, to prevent an                
apparent increase in false positive referrals. Second, deep learning software such as Pegasus,             
should clearly identify the types of imaging devices that give optimal performance and             
preferably contain an image quality module which indicates the suitability of images for             
automated analysis. Finally, caution should be taken when assessing the performance of deep             
learning software on high quality, curated, public datasets that may not necessarily            
correspond well to the realities of clinical practise. 
 
Despite these limitations, the performance of Pegasus is favourable when compared to similar             
systems from studies in the literature. For example, Rajalakshmi et al. determined that a deep               
learning system obtained a sensitivity of 99.3% (95% CI: 96.1-99.9) and specificity of 68.8%              
(95% CI: 61.5-76.2) for the detection of RDR from a non-handheld, but portable,             
smartphone-based fundus camera.​11 Pegasus achieved a sensitivity of 81.6% (95% CI:           
83.9-90.2) and a specificity of 81.7% (95% CI: 85.7-89.7) for RDR, which amounts to 17.7%               
drop in sensitivity but a 12.9% improvement in specificity over the system evaluated by              
Rajalakshmi et al.​11 In terms of RDR prediction, Rajalakshmi et al.​11 report a sensitivity of               
78.1% (95% CI: 63.8- 83.3) and specificity was 89.8% (86.1, 93.4), compared to the 86.6%               
(95% CI: 78.9-93.5) sensitivity and 87.7% (95% CI: 87.0-88.4) specificity obtained by            
Pegasus. 
 
The performance of Pegasus, even when a handheld device is used, also compares favourably              
to the performance reported in the literature using conventional cameras in a clinical setting.              
In a study by Tufail et al. the sensitivity for RDR detection varied from 85.0% to 93.8%, and                  
 
the specificity from 19.9% to 52.3%, depending on the deep learning system used.​12 One of               
the systems evaluated could not handle disc-centred images, and gave a sensitivity of 100%              
but a specificity of 0%.​10 In this study, it was determined that Pegasus could handle               
disc-centred images but there was a small decrease in performance, as would be expected              
since DR features at the periphery would not be captured in disc-centred images. In addition,               
a paper by Ting et al. showed a sensitivity of between 91 and 100% and a specificity of 91 to                    
92% for detecting RDR in a large sample of 76,370 images from multi-ethnic cohorts, which               
is similar to the performance of Pegasus on the benchmark dataset.​13 
 
In a study by Gulshan et al., a deep learning algorithm was developed and validated for RDR                 
against two datasets of images captured from conventional cameras; EyePACS-1 and           
Messidor-2.​14 Under the high sensitivity operating point the algorithm obtained a 97.5%            
sensitivity and 93.4% specificity on EyePACS-1 and 96.1% sensitivity and 93.9% specificity            
on Messidor-2. Importantly, poor quality images had been removed by clinicians, and so the              
results reported are not necessarily comparable to the real-world clinical setting and use of a               
product such as Pegasus as reported in this study or by Tufail et al.​10 Nevertheless, on the                 
conventional camera used in this study as a benchmark, Pegasus performs similarly with             
93.4% (95% CI: 90.8-95.8) sensitivity and 94.2% (95% CI: 91.0-97.2) specificity. However,            
the results could not be compared for PDR, since they are not reported by the authors.​13 
 
A strength of this study is the evaluation of the deep learning system ‘out of the box’. The                  
system was evaluated on unseen, real-world clinical data from a handheld fundus camera.             
The reported performance of the system, which was not specifically designed for images             
from handheld cameras, would likely improve if the system had ‘learned’ from images             
 
captured by either the handheld or conventional fundus cameras evaluated. This study was             
performed on a large patient cohort (5,752 patients; 22,180 images) which is highly             
representative of the sorts of images that would be acquired in remote retinal screening              
programmes. Furthermore, the system demonstrates its scalability through parallel analysis of           
multiple images at once. 
Conclusion 
The combination of handheld fundus imaging and AI assistance has great promise in             
improving the ability to screen patients in remote geographic locations where there is a              
shortage of ophthalmologists. To our knowledge, this study is the first to evaluate the              
performance of an artificial intelligence system on fundus images from a fully portable,             
handheld device, and the first comparison of performance on handheld versus performance on             
conventional cameras. 
 
Several AI systems for the grading of DR have been released in recent years.​10,12,13 The               
majority of published work has shown good performance on images captured using desktop             
fundus cameras. In this study, it was demonstrated that one such AI system, Pegasus,              
achieves performance comparable to state-of-the-art​11,13,14 on images acquired using a desktop           
fundus camera​7 yet generalises to images captured by a handheld camera, without            
adjustments, in the detection of PDR. Due to the limitations of this study, further work will                
have to be conducted to determine the level of generalisation of RDR. 
 
Artificial Intelligence systems such as Pegasus offer the intriguing possibility of distributed            
telemedicine, when used in conjunction with handheld screening devices, for accessible and            
 
high-quality care. Importantly, one of the benefits of such systems is the lack of variability               
and speed in decision making. With the number of patients with diabetic retinopathy likely to               
grow exponentially in the next two decades, newer sustainable models of care will need to be                
embedded and legacy clinical systems upgraded. Whilst showing considerable promise,          
further work is required to identify the clinical and economic ‘downstream’ effects of such              
Artificial Intelligence systems in practice. 
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Figure legends 
Figure 1. ​Examples of images used in this study. ​Left​: From the benchmark dataset (IDRiD), 
captured using a desktop (VX-10 alpha, Kowa American Corp., USA) fundus camera. ​Right​: 
From MAILOR, captured using a portable handheld (Pictor Plus, Volk Optical Inc., USA) 
fundus camera. 
 
Figure 2. ​CONSORT-style diagram for the MAILOR cohort. 
Figure 3.​ Receiver Operating Characteristic (ROC) curves for Pegasus measured on the 
MAILOR patient cohort for RDR and PDR. The shaded regions indicate the estimated 95% 
confidence intervals on the ROC curves. 
 
Figure 4.​ Selected examples of false positives for RDR detection from the MAILOR study. 
Exudate (left) and haemorrhage (right) detections by Pegasus are overlaid on the images as 
white bounding boxes and pink and blue heatmaps, respectively. Image zooms are inset for 
features detected by Pegasus that are difficult to see. 
 
Figure 5. ​Receiver Operating Characteristic (ROC) curves for Pegasus measured on the 
IDRiD patient cohort for RDR and PDR. The shaded regions indicate the estimated 95% 
confidence intervals on the ROC curves. 
 
 
 
Tables 
Table 1: ​Summary characteristics of eligible patients from the MAILOR cohort and the 
benchmark dataset. 
 MAILOR dataset IDRiD dataset 
Number of patients (images) 5,752 (22,180) - (516) 
Age, years ± SD (min-max) 60.0 ± 11.2 (8-100) - 
Female, No. (% patients) 3,785 (65.8%) - 
Diabetic, No. (% patients) 4,646 (80.8%) - (100%) 
Fields, No. (% images) 
● Macula-centred 
● Disc-centred 
 
11,090 (50.0%) 
11,090 (50.0%) 
 
516 (100%) 
0 (0%) 
Disease severity distribution (CRS) 
● No diabetic retinopathy 
● Referable diabetic retinopathy 
● Proliferative diabetic retinopathy 
 
5,017 (87.22%) 
595 (10.34%) 
60 (1.04%) 
 
168 (32.6%) 
323 (52.6%) 
62 (12.0%) 
 
 
 
 
 
 
 
 
 
 
Table 2: ​Performance of the AI system, Pegasus, for the detection of Referable Diabetic 
Retinopathy (RDR) and Proliferative Diabetic Retinopathy (PDR) from the benchmark 
desktop and handheld fundus devices.  
 
Fundus 
Camera 
DR 
Severity 
Sensitivity, %  
(95% CI) 
Specificity, 
% 
(95% CI) 
AUROC, % 
(95% CI) 
Benchmark 
(IDRiD): 
Desktop 
Kowa VX-10 
alpha 
RDR 93.4  (90.8-95.8) 
94.2  
(91.0-97.2) 
98.5  
(97.8-99.2) 
PDR 83.7  (74.5-91.8) 
84.6  
(81.5-87.7) 
92.2  
(89.4-94.8) 
MAILOR 
study: 
Handheld 
Volk Pictor 
Plus 
RDR 81.6 (79.0-84.2) 
81.7 
(80.9-82.6) 
89.4  
(88.0-90.7) 
PDR 86.6  (78.9-93.5) 
87.7 
(87.0-88.4) 
94.3  
(91.0-96.9) 
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